Table 2.
Baseline laboratory data including systemic immune-inflammation markers of COVID-19 patients treated in a German tertiary care hospital.
| Parameter | Data |
|---|---|
|
C-reactive protein (mg/L) median (range) |
36.3 (1–558) |
|
Lactate dehydrogenase (U/L) median (range) |
261.5 (86–1156) |
|
Ferritin (ng/mL) median (range) |
409 (5–10,627) |
|
Neutrophils (/µL) median (range) |
3955 (900–18,200) |
|
Lymphocytes (/µL) median (range) |
1090 (240–5090) |
|
Monocytes (/µL) median (range) |
440 (70–7300) |
|
Eosinophils (/µL) median (range) Eosinopenia (<40/µL) no/yes Absolute eosinopenia (0/µL) no/yes |
10 (0–480) 105/307 (25.5%/74.5%) 228/184 (55.3%/44.7%) |
|
Thrombocytes (/µL) median (range) |
189,000 (24,000–784,000) |
|
Neutrophil-to-lymphocyte ratio median (range) healthy controls |
3.7 (0.55–72.6) 1.9 (0.9–11.6) p < 0.0001 |
|
Systemic immune-inflammation index median (range) healthy controls |
688 (39.7–14,661) 425 (39.3–5946) p = 0.0002 |
|
Pan-immune-inflammation value median (range) healthy controls |
288 (16.8–24,338) 275 (81–1621) p = 0.47 |